IGRA Test for TB: What It Is, Procedure and What Your Result Means

An IGRA, or Interferon-Gamma Release Assay, is a blood test that determines whether the immune system has been exposed to tuberculosis bacteria.

It works by mixing a blood sample with proteins derived from Mycobacterium tuberculosis antigens and then measuring whether white blood cells respond by releasing interferon-gamma, a signaling molecule the immune system produces when it recognizes TB.

A strong interferon-gamma response indicates that the immune system has encountered TB bacteria at some point.

That encounter may have produced latent infection, where bacteria are present but contained and inactive, or active TB disease, where bacteria are multiplying and causing symptoms. 

The IGRA test alone cannot distinguish between these two states. What it reliably confirms is whether TB infection has occurred at all.

In India, where BCG vaccination is administered at birth to the vast majority of the population, the TB skin test carries a significant limitation: the vaccine can trigger a positive skin reaction that is indistinguishable from a reaction caused by actual TB exposure. 

IGRA uses antigens that are absent from the BCG vaccine strain, which means vaccination history does not affect the result.

This is why IGRA has become the preferred test for TB screening in BCG-vaccinated populations.

An IGRA test for TB is recommended when a reliable TB screening result is needed and BCG vaccination history would complicate the interpretation of a skin test result.

Specific groups where IGRA testing is clinically indicated include healthcare workers undergoing routine occupational TB screening, individuals who have had known or suspected TB exposure, people starting immunosuppressive therapy such as biologics or long-term corticosteroids, and those being evaluated for TB before organ transplantation.

The IGRA procedure requires a single blood draw at one visit. No fasting, no special preparation, and no skin injection are involved.

IGRA results are reported in one of three categories, and each has a defined next step.

A positive result indicates that the blood sample showed a significant interferon-gamma response to TB antigens.

This means TB bacteria are or have been present in the body. It does not confirm whether the infection is currently active or dormant. Further investigation is required before any treatment decision is made.

A negative result indicates that no significant interferon-gamma response was detected. This generally means TB infection is unlikely.

In individuals with severely compromised immune function, the immune system may not mount a detectable response even when infection is present, which is a known limitation of the test in this population.

An indeterminate result occurs when the test controls do not perform within expected parameters, making the result uninterpretable.

This requires the test to be repeated. Indeterminate results are more common in individuals with conditions that affect immune function.

What happens after a positive result

A positive IGRA is the beginning of the diagnostic pathway, not its conclusion.

The standard next steps are a chest X-ray to assess whether active pulmonary TB is present and sputum testing if active disease is suspected. 

The combination of IGRA results, chest X-ray findings, sputum culture results, and clinical symptoms is what determines whether a person has a latent TB infection requiring preventive treatment or active TB disease requiring full treatment.

Advantages

The single-visit requirement removes the most common practical barrier to TB screening.

A patient who cannot return two days later for a skin test reading will get no result at all. IGRA eliminates that gap.

The BCG vaccine's independence is clinically significant in the Indian context.

A positive skin test in a BCG-vaccinated person cannot reliably be distinguished from a vaccine reaction, which means false positives drive unnecessary investigations and treatment. IGRA produces a result that stands regardless of vaccination history.

Higher specificity reduces false positives in low-prevalence settings and in populations where BCG vaccination is universal.

Limitations

IGRA cannot on its own distinguish latent TB infection from active TB disease.

This is not a weakness of the test but a reflection of what antibody and cellular immune responses can and cannot tell clinicians about disease stage.

Imaging and microbiological testing are always required to complete the diagnostic picture.

A positive or indeterminate IGRA result creates an immediate need: clinical interpretation, appropriate follow-up imaging, and specialist guidance on whether preventive or active treatment is indicated. 

For most employees, navigating this pathway across multiple providers creates delays that affect both clinical outcomes and workplace continuity.

Diagnostics: 8,500+ NABL-Accredited Labs. Employees can book an IGRA test cashlessly through Visit Health's diagnostic network across India.

Home sample collection is available, and results are tracked digitally through the app without requiring a physical report collection visit.

Teleconsultation: Internal Medicine and Pulmonology. A positive TB blood test result requires specialist interpretation in a clinical context, not a reading of the laboratory report in isolation.

Visit Health's teleconsultation platform connects employees with internal medicine and pulmonology specialists across 30+ specialties, same day, without a hospital visit or a separate referral.

AI-Powered Smart Reports: An IGRA result alongside chest X-ray findings, sputum test outcomes, and clinical history involves multiple data points that most patients cannot synthesise without guidance. 

Visit Health's Smart Reports to convert the combined findings into plain-language summaries, clarifying what each result indicates and what the recommended next step is.

Visit Clinic: Bengaluru (Marathahalli, Outer Ring Road). For employees in Bengaluru who need an in-person consultation, a chest X-ray referral, or a direct specialist appointment following a positive IGRA result, Visit Clinic provides on-ground appointments connected to the broader diagnostic and specialist ecosystem.

An IGRA test for TB provides a single-visit, BCG-unaffected answer to one of the most clinically important screening questions in the Indian workplace context: has this person been infected with TB bacteria.

It does not complete the diagnostic picture on its own, but it is the most reliable and practical starting point currently available for tuberculosis diagnosis in a BCG-vaccinated population.

What does IGRA stand for? 

Interferon-Gamma Release Assay. A blood test that measures the immune system's response to TB-specific proteins to determine whether TB infection has occurred.

How is an IGRA test done? 

Through a single blood draw at one visit. The sample is sent to a laboratory where it is mixed with TB antigens and analyzed for an interferon-gamma response. No return visit is required.

Does the BCG vaccine affect IGRA results? 

No. IGRA uses antigens that are absent from the BCG vaccine strain, so prior BCG vaccination does not cause a false positive. This is the primary advantage of IGRA over the TB skin test in India.

What does a positive IGRA test mean? 

That TB bacteria are or have been present in the body. Further investigations, including a chest X-ray and sputum test where indicated, are needed to determine whether the infection is latent or active.

Can IGRA distinguish between latent TB and active TB disease? 

No. IGRA confirms TB infection but cannot determine whether that infection is currently active or dormant. Chest X-ray, sputum culture, and clinical assessment together provide that distinction.

Is IGRA more accurate than the TB skin test? 

IGRA has higher specificity, particularly in BCG-vaccinated populations, because it uses TB-specific antigens that do not cross-react with the vaccine strain. For individuals who have received BCG, IGRA is generally the more reliable test.

How long does it take to get IGRA test results? 

Typically, one to three working days, depending on the laboratory processing the sample.

Can employees get an IGRA TB blood test through Visit Health? 

Yes. Through Visit Health's OPD benefit, cashlessly across 8,500+ NABL-accredited labs, with home sample collection, digital result tracking, and same-day teleconsultation for specialist interpretation.

Prioritise workplace TB screening access, a cashless IGRA blood test through Visit Health with same-day specialist result interpretation.